UNLIMITED TURBO BULL - AMGEN | Real-time Euronext Paris 10:13:45 2024-04-29 am EDT | ||
| 6.43 EUR | +5.93% |
|
| Current month | -20.76% | ||
| 1 month | -18.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 6.43 | +5.93% | 76 |
| 24-04-26 | 6.07 | +2.53% | 90 |
| 24-04-25 | 5.92 | -8.64% | 101 |
| 24-04-24 | 6.48 | +0.31% | 83 |
| 24-04-23 | 6.46 | +2.22% | 82 |
Real-time Euronext Paris
Last update April 29, 2024 at 10:13 am EDT
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| 318CS | |
| ISIN | DE000SF52660 |
| Date issued | 2021-10-26 |
| Strike | 205.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.04 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.87 € |
|---|---|
| Lowest since issue | 2.155 € |
| Spread | 0.12 € |
| Spread % | 1.94% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
270
USD
Average target price
300.3
USD
Spread / Average Target
+11.22%
- Stock Market
- Certificates
- 318CS Certificat
